|
Market Closed -
Nasdaq
00:00:00 17/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.2310 USD | -3.47% |
|
-2.94% | -76.90% |
| 10-01 | TScan Therapeutics, Inc. Announces Departure of Chrystal Louis as Chief Medical Officer | CI |
| 10-01 | TScan Therapeutics, Inc. Announces Cessation of Jason A. Amello as Chief Financial Officer | CI |
| Market Cap | 15.66M 13.92M 12.9M 11.74M 22.15M 1.49B 22.5M 155M 60.79M 775M 58.76M 57.51M 2.47B | P/E 2026 * |
-0.29x | P/E 2027 * | -0.39x |
|---|---|---|---|---|---|
| Enterprise Value | 15.66M 13.92M 12.9M 11.74M 22.15M 1.49B 22.5M 155M 60.79M 775M 58.76M 57.51M 2.47B | EV / Sales 2026 * |
5.36x | EV / Sales 2027 * | 12.5x |
| Free-Float |
92.04% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| TCRX | Delayed | |
CBOE
| TCRX | Real-time |
Last Transcript: TScan Therapeutics, Inc.
| 1 day | -3.47% | ||
| 1 week | -2.94% | ||
| Current month | -26.55% | ||
| 1 month | -30.21% | ||
| 3 months | -74.29% | ||
| 6 months | -78.61% | ||
| Current year | -76.90% |
| 1 week | 0.2 |  | 0.25 |
| 1 month | 0.2 | | 0.37 |
| Current year | 0.2 | | 1.47 |
| 1 year | 0.2 | | 2.55 |
| 3 years | 0.2 | | 9.69 |
| 5 years | 0.2 | | 9.69 |
| 10 years | 0.2 | | 14.71 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gavin MacBeath
CEO | Chief Executive Officer | 56 | 28/03/2023 |
Dawn Pinchasik
CTO | Chief Tech/Sci/R&D Officer | - | 06/02/2024 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Katina Dorton
BRD | Director/Board Member | 68 | 23/03/2021 |
Gavin MacBeath
BRD | Director/Board Member | 56 | 24/05/2023 |
Stephen Biggar
CHM | Chairman | 55 | 12/06/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 01/10/26 | Free | Chief Executive Officer | 1,000,000 | 1.5747% | ||
| 01/10/26 | Free | General Counsel | 300,000 | 0.4724% | ||
| 20/05/26 | Free | Director | 67,000 | 0.1200% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.47% | -2.94% | -90.69% | -93.46% | 15.66M | |
| -6.60% | -8.56% | +42.79% | +64.16% | 65B | |
| -4.09% | -0.11% | +2.31% | +54.81% | 51.19B | |
| +0.03% | +5.56% | +10.18% | +41.75% | 51.2B | |
| -1.53% | +2.70% | +29.72% | +34.13% | 43.93B | |
| -1.34% | +4.12% | +16.05% | +112.18% | 41.96B | |
| -5.97% | -6.22% | +258.21% | +421.57% | 38.14B | |
| +6.53% | +8.02% | +15.74% | +53.94% | 33.24B | |
| -0.90% | -10.49% | +31.48% | -1.63% | 25.2B | |
| -2.76% | -9.54% | -16.53% | -9.55% | 22.03B | |
| Average | -2.01% | -1.80% | +29.93% | +67.79% | 37.19B | |
| Weighted average by Cap. | -2.30% | -1.21% | +43.56% | +88.57% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.92M 2.6M 2.41M 2.19M 4.13M 277M 4.2M 28.93M 11.34M 145M 10.96M 10.73M 461M | 1.25M 1.11M 1.03M 937K 1.77M 119M 1.8M 12.38M 4.85M 61.91M 4.69M 4.59M 197M |
| Net income | -105M -93.21M -86.39M -78.6M -148M -9.95B -151M -1.04B -407M -5.19B -394M -385M -16.56B | -79.1M -70.31M -65.17M -59.29M -112M -7.51B -114M -783M -307M -3.92B -297M -291M -12.49B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/10/26 | $0.2310 | -3.47% | 568,383 |
| 15/10/26 | $0.2393 | +13.63% | 878,839 |
| 14/10/26 | $0.2106 | -2.81% | 546,839 |
| 13/10/26 | $0.2167 | -8.91% | 461,372 |
| 12/10/26 | $0.2379 | -0.04% | 483,537 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TCRX Stock
Select your edition
All financial news and data tailored to specific country editions
